ARMISTICE CAPITAL, LLC - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 162 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$19,200,000
+53.3%
20,000,000
+19.8%
0.28%
+54.4%
Q1 2023$12,525,000
+99.9%
16,700,000
-1.8%
0.18%
+65.1%
Q4 2022$6,264,500
-12.6%
17,000,000
+1.9%
0.11%
-12.1%
Q3 2022$7,171,000
-46.2%
16,676,000
-2.5%
0.12%
-46.8%
Q2 2022$13,338,000
-39.5%
17,100,0000.0%0.23%
-45.4%
Q1 2022$22,059,000
+79.7%
17,100,000
+76.9%
0.43%
+112.4%
Q4 2021$12,276,000
-65.7%
9,665,756
-41.1%
0.20%
-66.8%
Q3 2021$35,752,000
-13.7%
16,400,000
+48.4%
0.61%
-18.3%
Q2 2021$41,430,000
+18.8%
11,048,000
+3.3%
0.74%
-7.4%
Q1 2021$34,882,000
+6.6%
10,700,000
+11.6%
0.80%
-28.0%
Q4 2020$32,709,000
+5.9%
9,592,000
+26.7%
1.11%
-0.8%
Q3 2020$30,894,000
+49.9%
7,572,000
+292.7%
1.12%
-0.6%
Q1 2019$20,610,000
+57.0%
1,928,000
+28.5%
1.13%
+13.4%
Q4 2018$13,125,000
-56.7%
1,500,000
-66.2%
1.00%
-90.9%
Q2 2015$30,342,000
+85.1%
4,436,000
+64.3%
10.90%
+50.0%
Q1 2015$16,389,000
+15.3%
2,700,000
+31.6%
7.26%
+6.3%
Q4 2014$14,220,0002,052,0006.83%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Piermont Capital Management Inc. 312,842$2,033,0000.48%
BARD ASSOCIATES INC 648,525$4,215,0000.39%
Sonora Investment Management, LLC 233,295$1,516,418,0000.30%
Nine Chapters Capital Management LLC 32,400$211,0000.28%
Alambic Investment Management, L.P. 287,601$1,869,0000.23%
Granite Investment Partners, LLC 201,221$1,308,0000.09%
Renaissance Technologies 5,679,800$36,919,0000.05%
PDT Partners, LLC 123,200$801,0000.04%
ClariVest Asset Management LLC 242,050$1,573,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 315,934$2,054,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders